Home » Centro de Ingeniería Genética y Biotecnología

B-8

banners_soya_1920x850

banners_home-peptido_1920x850

banners_home3_1920x850

banners_home1_1920x850

banners_home_plantas1920x850

banners_home_1920x8501

banners_home_1920x850

banners_home_1920x850-1

We focus on

+10 therapeutic areas

We study

+50 diseases

We commercialize in

+35 countries

Message from the Director General

“We have been able to motivate young people to become what we have become. We had the opportunity to work with a very committed generation, and we have a duty to follow that example.”

PhD. Marta Ayala Ávila

General Director

Our studies focus on

Research areas

Biomedicine

Research and development of vaccines and biopharmaceuticals for the diagnosis, treatment and prevention of diseases.

Animal Biotechnology

Research and development of biomolecules, vaccines and diagnostics to veterinary medicine and aquatic organisms.

Plant biotechnology

Genetic transformation of plants and development of diagnostic systems for the control of pests and phytopathogens.

Industrial Enzymes

Agricultural biotechnology is applied to the design of industrial enzymes, with impact on the quality and production of...

Why CIGB?

We are challenged to achieve high added value innovative products

that generate a positive impact on human, animal and plant health, as well as industrial productions, in harmony with the environment, to contribute to the socioeconomic development of Cuba

Top-tier productive scientific complex

that develops vaccines, drugs and diagnostics for human, animals and plants

COVID-19 vaccines and products

Novel and traditional that are used in Cuban treatment protocols for COVID-19, such as the Abdala vaccine. Cuba deploys mass vaccination of its population with its own vaccines.

Food sustainability

of the nation is prioritized through own scientific solutions that raise productive performance

Our directives

PhD. Marta Ayala Ávila

General Director

PhD. Jorge Valdés Hernández

Deputy Director General

PhD. Yassel Ramos Gómez

Deputy director

PhD. Gerardo Guillén Nieto

Director of Biomedical Research

PhD. Mario Pablo Estrada García

Director of Agricultural Research

PhD. Jorge Castro Velazco

Director of Preclinical Research and Animal Experimentation

PhD. Julio Esmir Baldomero Hernández

Director of Clinical Research

PhD. Odalys Ruiz Hernández

Director of Technological Development

Msc. Mabel Izquierdo López

Director of Quality Control

Ing. Jorge Luis Vega Elias

Production Director

Ing. Miriela Gil Mena

International Sales Director

PhD. Miladys Limonta Fernández

Director of Business Development

MSc. Yai Cruz Ruiseco

Director of Imports

See all

Abdala

First vaccine against COVID-19 in Latin America.

See Product

Results

Phase III clinical study of Abdala

Efficacy against symptomatic disease

92.28%

Efficacy in preventing severe systemic disease and death of vaccinated people

100%

Effectiveness in critically ill patients

90%

More than a vaccine, it is a country, we are all: those who made it possible and those who put their shoulders to try it; those who are immunized and those who will be.

PhD. Miguel Díaz-Canel Bermúdez

In Cuba we have the privilege, the pride to say that we have a vaccine [anticovid-19] that is the first in Latin America, with an emergency use authorization, developed and manufactured in the region.

MSc. Olga Lidia Jacobo Casanueva

A vaccine is never finished evaluating, after its certification, surveillance is maintained in the market and the process of releasing the manufactured batches is carried out to guarantee quality, safety and efficacy in the product.

MSc. Olga Lidia Jacobo Casanueva

There are many products of the Cuban industry that are unique and are applied in the Cuban action protocol [against COVID-19]. Even when we are in a moment of regrowth, we have tools, health technologies and the confidence that we are going to know manage this current situation and one of those tools is vaccines.

Dra. Marta Ayala Ávila

Upcoming events

Where you can know our results

11Jun

Biocubagro 2025

8 Jun, 2025 13 Jun, 2025

The Center for Genetic Engineering and Biotechnology of Havana (CIGB) and the Organizing Committee...

11Jun

IS3DV

8 Jun, 2025 13 Jun, 2025

We are delighted to invite scientists, students, and colleagues with an interest in Virology...

3Jul

V International Symposium Cancer 2025

3 Jul, 2025 7 Jul, 2025

Welcome The Center of Genetic Engineering and Biotechnology (CIGB) is pleased to announce the...

21Sep

Biomanufacturing 2025

21 Sep, 2025 27 Sep, 2025

Welcome Message, Dear Biotechnological Product Manufacturing Community, as Scientific Chairman, I would like to...

20Oct

1st International Congress on Clinical Research with Biopharmaceutical Products

20 Oct, 2025 24 Oct, 2025

WELCOME We are pleased to invite you to attend the 1st International Congress on...

See all

We work for one health

We offer + 25 products

Our products are preventive, therapeutic or diagnostic. We design products first and only of its kind for diseases that have no other effective therapeutic solutions.

See all

Animal products

HeberFast Line® Gavac

Recombinant proteins

Monoclonal antibodies

COVID-19

What do we work on?

Main processes

News

Last news

26Nov